Preclinical profiles of progestins used in formulations of oral contraceptives and hormone replacement therapy

This publication has 24 references indexed in Scilit:

• Crystal structure of human sex hormone-binding globulin: steroid transport by a laminin G-like domain
  The EMBO Journal, 2000
• Inhibition of skin 5α-reductase by oral contraceptive progestinsin vitro
  Gynecological Endocrinology, 2000
• Uniqueness of oral contraceptive progestins
  Contraception, 1998
• Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: A randomized, placebo-controlled trial
  Obstetrics & Gynecology, 1997
• Estrogen replacement therapy in practice: Trends and issues
  American Journal of Obstetrics and Gynecology, 1995
• Estrogen and interrupted progestin: A new concept for menopausal hormone replacement therapy
  American Journal of Obstetrics and Gynecology, 1993
• Relative binding affinity of norgestimate and other progestins for human sex hormone-binding globulin
  Steroids, 1990
• Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins
  Contraception, 1990
• Gestodene: A novel synthetic progestin — characterization of binding to receptor and serum proteins
  Contraception, 1989
• Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel
  Fertility and Sterility, 1984